Sandoz tests direct-to-consumer sales with Omnitrope, a growth hormone biosimilar

Sandoz unveiled a direct-to-consumer platform, starting off with a single medication for now as the generic drugmaker adopts a system that several brand-name manufacturers are using to cut out-of-pocket costs for some patients.

Raccontata daendpoints.news